Where Insulin-like Growth Factor-1 (IGF-1) is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Major Depressive Disorder | ↑ elevated | healthy controls | — | Arinami et al. 2023 |
Frequently asked questions
In which conditions is Insulin-like Growth Factor-1 (IGF-1) altered?
In the OSMF atlas Insulin-like Growth Factor-1 (IGF-1) is reported in Major Depressive Disorder. It is elevated in 1 across 1 entries.
Is there a standard clinical test for Insulin-like Growth Factor-1 (IGF-1)?
The atlas entries for Insulin-like Growth Factor-1 (IGF-1) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Insulin-like Growth Factor-1 (IGF-1) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.